{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:31:29Z","timestamp":1769635889341,"version":"3.49.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12264-017-0160-z","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T04:34:31Z","timestamp":1501475671000},"page":"543-551","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"33","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaofei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"160_CR1","first-page":"151","volume":"106","author":"M Grasso","year":"2015","unstructured":"Grasso M, Piscopo P, Crestini A, Confaloni A, Denti MA. Circulating microRNAs in neurodegenerative diseases. EXS 2015, 106: 151\u2013169.","journal-title":"EXS"},{"key":"160_CR2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J and Yearout D, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease. Nat Genet 2010, 42: 781\u2013785.","journal-title":"Nat Genet"},{"key":"160_CR3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2015.04.042","volume":"449","author":"P Rosa De","year":"2015","unstructured":"De Rosa P, Marini ES, Gelmetti V, Valente EM. Candidate genes for Parkinson disease: Lessons from pathogenesis. Clin Chim Acta 2015, 449: 68\u201376.","journal-title":"Clin Chim Acta"},{"key":"160_CR4","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A. Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2012, 2: a008888.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"160_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737175.2015.1114886","volume":"17","author":"A Saghazadeh","year":"2015","unstructured":"Saghazadeh A, Rezaei N. MicroRNA machinery in Parkinson\u2019s disease: a platform for neurodegenerative diseases. Expert Rev Neurother 2015, 17: 1\u201327.","journal-title":"Expert Rev Neurother"},{"key":"160_CR6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa AA, Chakravarthy S, Phillips JR, Gupta A, Keri S, Polner B, et al. Motor symptoms in Parkinson\u2019s disease: A unified framework. Neurosci Biobehav Rev 2016, 68: 727\u2013740.","journal-title":"Neurosci Biobehav Rev"},{"key":"160_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JPD-012144","volume":"2","author":"SK Khoo","year":"2012","unstructured":"Khoo SK, Petillo D, Kang UJ, Resau JH, Berryhill B, Linder J, et al. Plasma-based circulating MicroRNA biomarkers for Parkinson\u2019s disease. J Parkinsons Dis 2012, 2: 321\u2013331.","journal-title":"J Parkinsons Dis"},{"key":"160_CR8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","volume":"125","author":"AJ Hughes","year":"2002","unstructured":"Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125: 861\u2013870.","journal-title":"Brain"},{"key":"160_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 2006, 5: 235\u2013245.","journal-title":"Lancet Neurol"},{"key":"160_CR10","first-page":"489830","volume":"2012","author":"F Copped","year":"2012","unstructured":"Copped F. Genetics and epigenetics of Parkinson\u2019s disease. Sci World J 2012, 2012: 489830.","journal-title":"Sci World J"},{"key":"160_CR11","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.cca.2012.05.021","volume":"413","author":"JL Garcia-Gimenez","year":"2012","unstructured":"Garcia-Gimenez JL, Sanchis-Gomar F, Lippi G, Mena S, Ivars D, Gomez-Cabrera MC, et al. Epigenetic biomarkers: A new perspective in laboratory diagnostics. Clin Chim Acta 2012, 413: 1576\u20131582.","journal-title":"Clin Chim Acta"},{"key":"160_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.pmbts.2016.12.013","volume":"146","author":"S Kumar","year":"2017","unstructured":"Kumar S, Vijayan M, Bhatti JS, Reddy PH. MicroRNAs as peripheral biomarkers in aging and age-related diseases. Prog Mol Biol Transl Sci 2017, 146: 47\u201394.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"160_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.neuro.29.051605.112839","volume":"29","author":"X Cao","year":"2006","unstructured":"Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH. Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci 2006, 29: 77\u2013103.","journal-title":"Annu Rev Neurosci"},{"key":"160_CR14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9: 654\u2013659.","journal-title":"Nat Cell Biol"},{"key":"160_CR15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/jnnp-2013-307539","volume":"85","author":"N Magdalinou","year":"2014","unstructured":"Magdalinou N, Lees AJ, Zetterberg H. Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions. J Neurol Neurosurg Psychiatry 2014, 85: 1065\u20131075.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"160_CR16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fgene.2013.00115","volume":"4","author":"A Etheridge","year":"2013","unstructured":"Etheridge A, Gomes CP, Pereira RW, Galas D, Wang K. The complexity, function and applications of RNA in circulation. Front Genet 2013, 4: 115.","journal-title":"Front Genet"},{"key":"160_CR17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597\u2013610.","journal-title":"Nat Rev Genet"},{"key":"160_CR18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-319-22671-2_6","volume":"888","author":"L Qiu","year":"2015","unstructured":"Qiu L, Tan EK, Zeng L. microRNAs and neurodegenerative diseases. Adv Exp Med Biol 2015, 888: 85\u2013105.","journal-title":"Adv Exp Med Biol"},{"key":"160_CR19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008, 9: 102\u2013114.","journal-title":"Nat Rev Genet"},{"key":"160_CR20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fncel.2013.00178","volume":"7","author":"EF Goodall","year":"2013","unstructured":"Goodall EF, Heath PR, Bandmann O, Kirby J, Shaw PJ. Neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Front Cell Neurosci 2013, 7: 178.","journal-title":"Front Cell Neurosci"},{"key":"160_CR21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","volume":"46","author":"MM Mouradian","year":"2012","unstructured":"Mouradian MM. MicroRNAs in Parkinson\u2019s disease. Neurobiol Dis 2012, 46: 279\u2013284.","journal-title":"Neurobiol Dis"},{"key":"160_CR22","first-page":"36","volume":"8","author":"AG Hoss","year":"2016","unstructured":"Hoss AG, Labadorf A, Beach TG, Latourelle JC, Myers RH. microRNA Profiles in Parkinson\u2019s Disease Prefrontal Cortex. Front Aging Neurosci 2016, 8: 36.","journal-title":"Front Aging Neurosci"},{"key":"160_CR23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/hmg\/dds470","volume":"22","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Liu G, Jin SM, Parisiadou L, Xie C, Yu J, et al. MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 2013, 22: 608\u2013620.","journal-title":"Hum Mol Genet"},{"key":"160_CR24","doi-asserted-by":"crossref","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 2010, 285: 12726\u201312734.","journal-title":"J Biol Chem"},{"key":"160_CR25","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","volume":"20","author":"E Minones-Moyano","year":"2011","unstructured":"Minones-Moyano E, Porta S, Escaramis G, Rabionet R, Iraola S, Kagerbauer B, et al. MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function. Hum Mol Genet 2011, 20: 3067\u20133078.","journal-title":"Hum Mol Genet"},{"key":"160_CR26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ana.24384","volume":"77","author":"R Fernandez-Santiago","year":"2015","unstructured":"Fernandez-Santiago R, Iranzo A, Gaig C, Serradell M, Fern\u00e1ndez M, Tolosa E, et al. MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder. Ann Neurol 2015, 77: 895\u2013901.","journal-title":"Ann Neurol"},{"key":"160_CR27","doi-asserted-by":"crossref","first-page":"25443","DOI":"10.1371\/journal.pone.0025443","volume":"6","author":"M Martins","year":"2011","unstructured":"Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S, et al. Convergence of miRNA expression profiling, alpha-synuclein interacton and GWAS in Parkinson\u2019s disease. PLoS One 2011, 6: 25443.","journal-title":"PLoS One"},{"key":"160_CR28","doi-asserted-by":"crossref","first-page":"94839","DOI":"10.1371\/journal.pone.0094839","volume":"9","author":"K Burgos","year":"2014","unstructured":"Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, et al. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer\u2019s and Parkinson\u2019s diseases correlate with disease status and features of pathology. PLoS One 2014, 9: 94839.","journal-title":"PLoS One"},{"key":"160_CR29","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y, Liu H, Zhang L, Lv W, Hu X. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 2015, 6: 37043\u201337053.","journal-title":"Oncotarget"},{"key":"160_CR30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1134\/S0006297912080020","volume":"77","author":"EV Filatova","year":"2012","unstructured":"Filatova EV, Alieva AKh, Shadrina MI, Slominsky PA. MicroRNAs: possible role in pathogenesis of Parkinson\u2019s disease. Biochemistry (Mosc) 2012, 77: 813\u2013819.","journal-title":"Biochemistry (Mosc)"},{"key":"160_CR31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cbf.3224","volume":"34","author":"W Ma","year":"2016","unstructured":"Ma W, Li Y, Wang C, Xu F, Wang M, Liu Y. Serum miR-221 serves as a biomarker for Parkinson\u2019s disease. Cell Biochem Funct 2016, 34: 511\u2013515.","journal-title":"Cell Biochem Funct"},{"key":"160_CR32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature09191","volume":"466","author":"S Gehrke","year":"2010","unstructured":"Gehrke S, Imai Y, Sokol N, Lu B. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010, 466: 637\u2013641.","journal-title":"Nature"},{"key":"160_CR33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","volume":"82","author":"G Wang","year":"2008","unstructured":"Wang G, van der Walt JM, Mayhew G, Li YJ, Z\u00fcchner S, Scott WK, et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 2008, 82: 283\u2013289.","journal-title":"Am J Hum Genet"},{"key":"160_CR34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2011.10.002","volume":"133","author":"E Junn","year":"2012","unstructured":"Junn E, Mouradian MM. MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 2012, 133: 142\u2013150.","journal-title":"Pharmacol Ther"},{"key":"160_CR35","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1242\/jcs.086421","volume":"125","author":"D Yang","year":"2012","unstructured":"Yang D, Li T, Wang Y, Tang Y, Cui H, Tang Y, et al. miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J Cell Sci 2012, 125: 1673\u20131682.","journal-title":"J Cell Sci"},{"key":"160_CR36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jnr.23377","volume":"92","author":"T Botta-Orfila","year":"2014","unstructured":"Botta-Orfila T, Morat\u00f3 X, Compta Y, Lozano JJ, Falg\u00e0s N, Valldeoriola F, et al. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson\u2019s disease. J Neurosci Res 2014, 92: 1071\u20131077.","journal-title":"J Neurosci Res"},{"key":"160_CR37","doi-asserted-by":"crossref","first-page":"64932","DOI":"10.18632\/oncotarget.10751","volume":"7","author":"Y Cui","year":"2016","unstructured":"Cui Y, Li T, Yang D, Li S, Le W. miR-29 regulates Tet1 expression and contributes to early differentiation of mouse ESCs. Oncotarget 2016, 7: 64932\u201364941.","journal-title":"Oncotarget"},{"key":"160_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18632\/oncotarget.13905","volume":"8","author":"M Mo","year":"2017","unstructured":"Mo M, Xiao Y, Huang S, Cen L, Chen X, Zhang L, et al. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian. Oncotarget 2017, 8: 15\u201328.","journal-title":"Oncotarget"},{"key":"160_CR39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5607\/en.2016.25.1.14","volume":"25","author":"I Choi","year":"2016","unstructured":"Choi I, Woo JH, Jou I, Joe EH. PINK1 Deficiency decreases expression levels of mir-326, mir-330, and mir-3099 during brain development and neural stem cell differentiation. Exp Neurobiol, 2016. 25: 14\u201323.","journal-title":"Exp Neurobiol"},{"key":"160_CR40","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.M115.691352","volume":"291","author":"Amrita Datta Chaudhuri","year":"2016","unstructured":"Amrita Datta Chaudhuri, Doo Chul Choi, Savan Kabaria, Alan Tran, Eunsung Junn. MicroRNA-7 regulates the function of mitochondrial permeability transition pore by targeting VDAC1 expression. J Biol Chem 2016, 291: 6483\u20136493.","journal-title":"J Biol Chem"},{"key":"160_CR41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jbiotec.2011.01.023","volume":"152","author":"R Margis","year":"2011","unstructured":"Margis R, Margis R, Rieder CR. Identification of blood microRNAs associated to Parkinsonis disease. J Biotechnol 2011, 152: 96\u2013101.","journal-title":"J Biotechnol"},{"key":"160_CR42","doi-asserted-by":"crossref","unstructured":"Alieva AK, Filatova EV, Karabanov AV, IIIarioshkin SN, Limborska SA, Shadrina MI, et al. miRNA expression is highly sensitive to a drug therapy in Parkinson\u2019s disease. Parkinsonism Relat Disord 2015, 21: 72\u201374.","DOI":"10.1016\/j.parkreldis.2014.10.018"},{"key":"160_CR43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.0000000000001258","volume":"84","author":"A Serafin","year":"2015","unstructured":"Serafin A, Foco L, Zaniqni S, Blankenburg H, Picard A, Zanon A, et al. Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD. Neurology 2015, 84: 645\u2013653.","journal-title":"Neurology"},{"key":"160_CR44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnmol.2013.00010","volume":"6","author":"L Soreq","year":"2013","unstructured":"Soreq L, Salomonis N, Bronstein M, Greenberg DS, Israel Z, Bergman H, et al. Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes. Front Mol Neurosci 2013, 6: 10.","journal-title":"Front Mol Neurosci"},{"key":"160_CR45","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317: 1220\u20131224.","journal-title":"Science"},{"key":"160_CR46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.6026\/97320630009381","volume":"9","author":"P Shapshak","year":"2013","unstructured":"Shapshak P. Molecule of the month: miRNA and Parkinson\u2019s disease protein PARK2. Bioinformation 2013, 9: 381\u2013382.","journal-title":"Bioinformation"},{"key":"160_CR47","first-page":"194","volume":"3","author":"Y Saito","year":"2012","unstructured":"Saito Y, Saito H. MicroRNAs in cancers and neurodegenerative disorders. Front Genet 2012, 3: 194.","journal-title":"Front Genet"},{"key":"160_CR48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/cddis.2013.73","volume":"4","author":"L Alvarez-Erviti","year":"2013","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM. Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson\u2019s disease. Cell Death Dis 2013, 4: 545.","journal-title":"Cell Death Dis"},{"key":"160_CR49","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s12031-014-0428-y","volume":"54","author":"LF Cardo","year":"2014","unstructured":"Cardo LF, Coto E, Ribacoba R, Men\u00e9ndez M, Moris G, Su\u00e1rez E, et al. MiRNA profile in the substantia nigra of Parkinson\u2019s disease and healthy subjects. J Mol Neurosci 2014, 54: 830\u2013836.","journal-title":"J Mol Neurosci"},{"key":"160_CR50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fncel.2014.00156","volume":"8","author":"A Vallelunga","year":"2014","unstructured":"Vallelunga A, Raqusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, et al. Identification of circulating microRNAs for the differential diagnosis of Parkinson\u2019s disease and Multiple System Atrophy. Front Cell Neurosci 2014, 8: 156.","journal-title":"Front Cell Neurosci"},{"key":"160_CR51","doi-asserted-by":"crossref","first-page":"43571","DOI":"10.1038\/srep43571","volume":"7","author":"M Muthuraman","year":"2017","unstructured":"Muthuraman M, Deuschl G, Koirala N, Riedel C, Volkmann J, Groppa S. Effects of DBS in parkinsonian patients depend on the structural integrity of frontal cortex. Sci Rep 2017, 7: 43571.","journal-title":"Sci Rep"},{"key":"160_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0217-4","author":"A Kumar","year":"2016","unstructured":"Kumar A, Narayanan K, Chaudhary RK, Mishra S, Kumar S, Vinoth KJ, et al. Current perspective of stem cell therapy in neurodegenerative and metabolic diseases. Mol Neurobiol 2016. doi: 10.1007\/s12035-016-0217-4 .","journal-title":"Mol Neurobiol"},{"key":"160_CR53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fnana.2016.00123","volume":"10","author":"P Vald\u00e9s","year":"2016","unstructured":"Vald\u00e9s P, Schneider BL. Gene Therapy: A Promising approach for neuroprotection in Parkinson\u2019s disease? Front Neuroanat 2016, 10: 123.","journal-title":"Front Neuroanat"},{"key":"160_CR54","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00018-015-2093-x","volume":"73","author":"I Basak","year":"2016","unstructured":"Basak I, Patil KS, Aives G, Larsen JP, M\u00f8ller SG, et al. microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases. Cell Mol Life Sci 2016, 73: 811\u2013827.","journal-title":"Cell Mol Life Sci"},{"key":"160_CR55","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.drudis.2009.09.009","volume":"14","author":"R Roshan","year":"2009","unstructured":"Roshan R, Ghosh T, Scaria V, Pillai B. MicroRNAs: novel therapeutic targets in neurodegenerative diseases. Drug Discov Today 2009, 14: 1123\u20131129.","journal-title":"Drug Discov Today"},{"key":"160_CR56","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1093\/nar\/gkg707","volume":"31","author":"A Boutla","year":"2003","unstructured":"Boutla A, Delidakis C, Tabler M. Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res 2003, 31: 4973\u20134980.","journal-title":"Nucleic Acids Res"},{"key":"160_CR57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/jhg.2016.91","volume":"62","author":"M Molasy","year":"2017","unstructured":"Molasy M, Walczak A, Szaflik J, Szaflik JP, Majsterek I. MicroRNAs in glaucoma and neurodegenerative diseases. J Hum Genet 2017, 62: 105\u2013112.","journal-title":"J Hum Genet"},{"key":"160_CR58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2014.09.003","volume":"81","author":"J Conde","year":"2015","unstructured":"Conde J, Edelman ER, Artzi N. Target-responsive DNA\/RNA nanomaterials for microRNA sensing and inhibition: the jack-of-all-trades in cancer nanotheranostics? Adv Drug Deliv Rev 2015, 81: 169\u2013183.","journal-title":"Adv Drug Deliv Rev"},{"key":"160_CR59","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/wnan.1228","volume":"5","author":"S H\u00f6bel","year":"2013","unstructured":"H\u00f6bel S, Aigner A. Polyethylenimines for siRNA and miRNA delivery in vivo. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5: 484\u2013501.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"160_CR60","first-page":"636","volume":"84","author":"M Marz","year":"2015","unstructured":"Marz M, Ferracin M, Klein C. MicroRNAs as biomarker of Parkinson disease? Small but mighty. Neurology 2015, 84: 636\u2013638.","journal-title":"Small but mighty. Neurology"},{"key":"160_CR61","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature03315","volume":"433","author":"LP Lim","year":"2005","unstructured":"Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433: 769\u2013773.","journal-title":"Nature"},{"key":"160_CR62","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1261\/rna.563707","volume":"13","author":"G Easow","year":"2007","unstructured":"Easow G, Teleman AA, Cohen SM. Isolation of microRNA targets by miRNP immunopurification. RNA 2007, 13: 1198\u20131204.","journal-title":"RNA"},{"key":"160_CR63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach M, Schwanh\u00e4usser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455: 58\u201363.","journal-title":"Nature"},{"key":"160_CR64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","volume":"455","author":"D Baek","year":"2008","unstructured":"Baek D, Vill\u00e9n J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008, 455: 64\u201371.","journal-title":"Nature"},{"key":"160_CR65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/00207454.2016.1209754","volume":"127","author":"MS Batistela","year":"2017","unstructured":"Batistela MS, Josviak ND, Sulzbach CD, de Souza RL. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer\u2019s and Parkinson\u2019s Diseases. Int J Neurosci 2017, 127: 547\u2013558.","journal-title":"Int J Neurosci"},{"key":"160_CR66","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00415-013-6900-8","volume":"260","author":"LF Cardo","year":"2013","unstructured":"Cardo LF, Coto E, de Mena L, Ribacoba R, Moris G, Men\u00e9ndez M, et al. Profile of microRNAs in the plasma of Parkinson\u2019s disease patients and healthy controls. J Neurol 2013, 260: 1420\u20131422.","journal-title":"J Neurol"},{"key":"160_CR67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/1354750X.2015.1118544","volume":"21","author":"H Dong","year":"2016","unstructured":"Dong H, Wang C, Lu S, Yu C, Huang L, Feng W, et al. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson\u2019s disease. Biomarkers 2016, 21: 129\u2013137.","journal-title":"Biomarkers"},{"key":"160_CR68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","volume":"22","author":"H Ding","year":"2016","unstructured":"Ding H, Huang Z, Chen M, Wang C, Chen X, Chen J, et al. Identification of a panel of five serum miRNAs as a biomarker for Parkinson\u2019s disease. Parkinsonism Relat Disord 2016, 22: 68\u201373.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-017-0160-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-017-0160-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-017-0160-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T21:17:28Z","timestamp":1602623848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-017-0160-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s12264-017-0160-z","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]}}}